AstraZeneca PLC Ordinary Shares (AZN)

EBITDA

$5.16B

Quarterly · Period ending: · USD

AZN logo

AZN EBITDA

Latest reported$5.16B
AZN Quarterly EBITDA ($1.75B → $5.16B)
High-resolution chart · PNG

AZN ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
5,163,000,000
5,673,000,000
4,631,665,755
5,227,000,000
4,955,000,000
5,035,000,000
2,809,000,000
4,102,000,000
4,119,000,000
4,468,000,000
2,703,992,048
3,326,000,000
3,795,000,000
4,129,000,000
2,649,208,452
2,595,000,000
1,915,000,000
2,198,000,000
1,868,000,000
1,122,000,000
1,843,000,000
2,708,000,000
2,251,000,000
1,978,000,000
2,000,000,000
2,108,000,000
2,204,000,000
1,478,000,000
1,229,000,000
1,801,000,000
2,676,000,000
1,539,000,000
1,471,000,000
1,426,000,000
1,675,000,000
1,819,000,000
1,556,000,000
1,580,000,000
3,118,000,000
1,642,000,000
899,000,000
1,617,000,000
1,774,000,000
1,748,000,000
1,650,000,000
1,788,000,000
701,000,000
1,409,000,000
1,817,000,000
1,563,000,000
2,024,000,000
2,108,000,000
2,146,000,000
2,070,000,000
2,841,000,000
2,910,000,000
2,389,000,000
2,666,000,000
3,263,000,000
4,958,000,000
3,612,000,000
4,064,000,000
3,847,000,000
3,131,000,000
3,591,000,000
4,177,000,000
3,230,000,000
3,792,000,000
3,409,000,000
3,661,000,000
2,182,000,000
3,287,000,000
3,078,000,000
3,217,000,000
1,778,000,000
2,804,000,000
2,581,000,000
2,787,000,000
1,810,000,000
2,656,000,000
2,637,000,000
2,258,000,000
1,546,000,000
2,418,000,000
1,984,000,000
1,881,000,000
-3,204,000,000
1,463,000,000
1,355,000,000
1,386,000,000
1,168,000,000
1,594,668,569
1,070,751,196
1,567,580,234
968,802,852
1,138,995,068
1,296,000,000
1,524,000,000
3,440,794,349
1,224,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.